论文部分内容阅读
目的研究双环醇片治疗非酒精性脂肪性肝病的疗效。方法将97例非酒精脂肪肝患者随机分为两组,试验组49例,在进行基础治疗的同时接受每日口服双环醇片75mg治疗,对照组48例,仅进行基础治疗,疗程均为24周。治疗前后检测体重指数(BMI),腰围/臀围(W/H)和多项肝功能指标,同时进行B超检测,比较两组的疗效。结果治疗后,两组各项指标均得到改善,且试验组在降低血清氨基转移酶与B超积分方面明显优于对照组(P<0.01,P<0.05)。结论每日口服双环醇片75mg治疗非酒精脂肪肝有效。
Objective To study the efficacy of bicyclol tablets in the treatment of non-alcoholic fatty liver disease. Methods Ninety-seven patients with non-alcoholic fatty liver were randomly divided into two groups. In the experimental group, 49 cases were treated with 75 mg daily oral bicyclol tablets while 48 cases in the control group were treated only with basic treatment. The course of treatment was 24 week. Body mass index (BMI), waist circumference / hip circumference (W / H) and multiple liver function indexes before and after treatment were measured. B-ultrasound was also performed to compare the curative effect of the two groups. Results After treatment, the indexes in both groups were improved, and the experimental group was significantly better than the control group in reducing serum aminotransferase and B-sub-integral (P <0.01, P <0.05). Conclusion Daily oral bicyclic alcohol tablets 75mg non-alcoholic fatty liver effective.